Skip to main content
logo
CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.250
+0.120 (2.91%)
Dec 16, 2025, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
Probody Therapeutics
138.10M
Log In
Log In
Log In
Log In
Upgrade
Probody Therapeutics Growth
36.45%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
United States
138.10M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
36.45%
Log In
Log In
Log In
Log In
Upgrade